organophosphonates has been researched along with Lymphoma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Q; Chen, J; Chen, K; Duan, H; Geng, Q; Hu, L; Huang, H; Jiang, W; Lin, T; Rao, H; Wu, S; Xia, Z; Yao, M | 1 |
Bzowska, A; Glavas-Obrovac, L; Hashimoto, M; Hikishima, S; Magnowska, L; Suver, M; Yokomatsu, T | 1 |
Barozzi, P; Belletti, D; Forni, F; Luppi, M; Mucci, A; Riva, G; Ruozi, B; Tosi, G; Vandelli, MA | 1 |
Agnaf, MR; Coyle, PV; Feeney, SA; Gerlich, WH; McCaughey, C; McDougall, N; Watt, AP; Wend, UC | 1 |
Halfdanarson, TR; Kalokhe, U; Luppi, M; Markovic, SN | 1 |
Aubourg, A; Bacq, Y; d'Alteroche, L; Gaudy, C; Senecal, D | 1 |
HolĂ˝, A; Pohl, R; Pomeisl, K; Votruba, I | 1 |
Berezin, F; Janisch, L; Lane, LB; Mick, R; Ratain, MJ; Schilsky, RL; Vogelzang, NJ | 1 |
Allred, DV; Bell, JD; O'Neill, K; Wilson, HA | 1 |
1 trial(s) available for organophosphonates and Lymphoma
Article | Year |
---|---|
Phase I study of amonafide dosing based on acetylator phenotype.
Topics: Acetylation; Adenine; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Imides; Intercalating Agents; Isoquinolines; Lymphoma; Male; Middle Aged; Models, Biological; Naphthalimides; Neoplasms; Organophosphonates; Phenotype | 1993 |
8 other study(ies) available for organophosphonates and Lymphoma
Article | Year |
---|---|
The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; DNA, Viral; Drug Interactions; Female; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk; Virus Activation; Young Adult | 2016 |
Antiproliferative activity of purine nucleoside phosphorylase multisubstrate analogue inhibitors containing difluoromethylene phosphonic acid against leukaemia and lymphoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Guanine; Humans; Kinetics; Leukemia; Lymphoma; Organophosphonates; Purine-Nucleoside Phosphorylase; Substrate Specificity | 2010 |
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma.
Topics: Antiviral Agents; Cell Line, Tumor; Cidofovir; Cytosine; Flow Cytometry; Humans; Liposomes; Lymphoma; Magnetic Resonance Spectroscopy; Microscopy, Atomic Force; Organophosphonates | 2010 |
Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.
Topics: Adenine; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunologic Factors; Lymphoma; Male; Organophosphonates; Papua New Guinea; Phylogeny; Rituximab; Sequence Analysis, DNA; Tenofovir; Viral Load; Virus Activation | 2013 |
A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy.
Topics: Aged; Antineoplastic Agents; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; HIV Seronegativity; Humans; Immunophenotyping; Lymphoma; Male; Organophosphonates; Remission Induction | 2006 |
[Autoimmune thrombopenia associated with hepatitis B reactivation (reverse seroconversion) after autologous hematopoietic stem cell transplantation].
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Immunocompromised Host; Immunoglobulin G; Immunologic Factors; Lymphoma; Male; Middle Aged; Organophosphonates; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Transplantation, Autologous; Treatment Outcome | 2007 |
Syntheses of pyrimidine acyclic nucleoside phosphonates as potent inhibitors of thymidine phosphorylase (PD-ECGF) from SD-lymphoma.
Topics: Animals; Cell Line; Drug Design; Enzyme Inhibitors; Escherichia coli; Humans; In Vitro Techniques; Lymphoma; Mice; Organophosphonates; Pyrimidine Nucleosides; Rats; Thymidine Phosphorylase | 2007 |
Activities and interactions among phospholipases A2 during thapsigargin-induced S49 cell death.
Topics: Animals; Apoptosis; Arachidonic Acid; Arachidonic Acids; Cell Membrane; DNA Fragmentation; Enzyme Inhibitors; Lymphoma; Mice; Organophosphonates; Phospholipases A; Phospholipases A2; Thapsigargin; Tritium; Tumor Cells, Cultured | 2000 |